Mercer Global Advisors
BIVI icon

Mercer Global Advisors’s BioVie BIVI Stock Holding History

Mercer Global Advisors’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$116 Buy
+60
New +$94 ﹤0.01% 5958

Other funds holding BIVI

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.56B AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Mercer Global Advisors's BIVI Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in BioVie (BIVI) in Q2 2026: 60 shares worth $116. The stake represents ﹤0.01% of the portfolio and ranks #5958 among its holdings.

24 funds tracked by Wall St. Rank hold BIVI as of Q2 2026.

  • Mercer Global Advisors held 60 shares of BioVie worth $116 as of Q2 2026.
  • BioVie was a new Mercer Global Advisors position in Q2 2026.
  • BioVie made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5958 holding.
  • 24 funds tracked by Wall St. Rank held BioVie as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.